News25/Ratings0
Latest news
25 items- SECSEC Form 6-K filed by Huami Corporation6-K - Zepp Health Corp (0001720446) (Filer)
- 13D/GSEC Form SC 13G filed by Huami CorporationSC 13G - Zepp Health Corp (0001720446) (Subject)
- 13D/GSEC Form SC 13G/A filed by Huami Corporation (Amendment)SC 13G/A - Zepp Health Corp (0001720446) (Subject)
- SECSEC Form 6-K filed by Huami Corporation6-K - Zepp Health Corp (0001720446) (Filer)
- SECSEC Form 6-K filed by Huami Corporation6-K - Zepp Health Corp (0001720446) (Filer)
- 13D/GSEC Form SC 13G/A filed by Huami Corporation (Amendment)SC 13G/A - Zepp Health Corp (0001720446) (Subject)
- SECSEC Form 6-K filed by Huami Corporation6-K - Zepp Health Corp (0001720446) (Filer)
- SECSEC Form 20-F filed by Huami Corporation20-F - Zepp Health Corp (0001720446) (Filer)
- PR5Y Capital Closes on over $2 Billion for its Latest Dual-Currency FundsSHANGHAI, April 12, 2021 /PRNewswire/ -- Today, 5Y Capital announced the closing of its latest fundraising in USD and RMB, totaling over $2 billion. The new funds significantly exceeded the firm's original target and hit the hard caps in a very short time after initial launch. Investors in the new funds include both existing long-term LPs and globally well recognized new investors. The latest USD funds alone exceeded $1.7 billion, including 5Y's highly reputable early-stage venture fund and its first ever growth fund. Over the decades, 5Y Capital has gained a wealth of experience in venture investments, identified and supported outstanding entrepreneurs from scratch and helped them achieve
- SECSEC Form 6-K filed by Huami Corporation6-K - Zepp Health Corp (0001720446) (Filer)
- SECSEC Form 424B3 filed424B3 - Zepp Health Corp (0001720446) (Filer)
- SECSEC Form 6-K filed6-K - Zepp Health Corp (0001720446) (Filer)
- SECSEC Form 424B3 filed424B3 - Huami Corp (0001720446) (Filer)
- 13D/GSEC Form SC 13G/A filedSC 13G/A - Huami Corp (0001720446) (Subject)
- 13D/GSEC Form SC 13G/A filedSC 13G/A - Huami Corp (0001720446) (Subject)
- PRHuami Corp Invests $5 Million in Hyperfine Research D Round to Support Accelerated Application of Disruptive MRI TechnologyBEIJING & CUPERTINO, Calif.--(BUSINESS WIRE)--Huami Corp. (NYSE: HMI) today announced that it has invested $5 million in Hyperfine Research’s D round of funding, which closed on February 3, 2021. Huami’s mission is to connect health with technology, developing both consumer and industrial health technologies. The company believes its miniaturization engineering expertise dovetails with efforts to miniaturize medical imaging technology which can disrupt the locations, applications and costs of medical imaging. Hyperfine Research is pioneering MRI imaging with its portable Swoop system, which received FDA 510(K) clearance in August of 2020. “In the same way that new depth and granu
- 13D/GSEC Form SC 13G/A filedSC 13G/A - Huami Corp (0001720446) (Subject)
- 13D/GSEC Form SC 13G/A filedSC 13G/A - Huami Corp (0001720446) (Subject)
- PRKeep Hearts Healthy This Valentine’s Day with Amazfit SmartwatchesIRVINE, Calif.--(BUSINESS WIRE)--Amazfit, a global brand in the smart wearables market, is committed to connecting health with technology and is keeping hearts in mind this Valentine’s Day. Monitor heart rate and other important health metrics with an Amazfit smartwatch that matches any style and need. Whether treating yourself or your sweetheart, customers can save up to $30 off Amazfit’s latest products during the limited time Valentine’s Day Sale. Gifts for Your Valentine For the Stylish Sweetheart: The Amazfit GT series of smartwatches offer a fashion-forward design, while featuring comprehensive tools to help track heart rate, sleep quality, stress levels and more. Coming
- 13D/GSEC Form SC 13G filedSC 13G - Huami Corp (0001720446) (Subject)
- 13D/GSEC Form SC 13G/A filedSC 13G/A - Huami Corp (0001720446) (Subject)
- SECSEC Form 6-K filed6-K - Huami Corp (0001720446) (Filer)
- PRHuami Corporation to Hold 2020 Annual General Meeting on February 25, 2021BEIJING, Jan. 22, 2021 /PRNewswire/ -- Huami Corporation ("Huami" or the "Company") (NYSE: HMI), today announced that it will hold its 2020 Annual General Meeting of Shareholders (the "AGM") at Huami Co., Ltd. Building B2, zhongguancun No.1, No.81 Beiqing road, Haidian District, Beijing, China P.C.100094, at 2:00 pm (Beijing Time) on February 25, 2021. The purpose of the AGM is for the Company's shareholders to consider, and if thought fit, approve the change of the Company's legal name from "Huami Corporation" to "Zepp Health Corporation", and the change of the Company's trading symbol at the New York Stock Exchange from "HMI" to "ZEPP." The proposed name change and trading symbol change
- PRHuami to Host 2021 Strategy and Outlook Investor Fireside Chat with CEO Wang Huang on January 22BEIJING, Jan. 14, 2021 /PRNewswire/ -- Huami Corp. (NYSE: HMI) today announced that it will hold a Fireside Chat conference call for investors on Friday, 22 January 2021. The company will discuss its 2021 strategies for consumer and industrial health technologies, including its product plans announced at the Consumer Electronics Show and new partnerships in medical imaging. Speakers will include Chairman, CEO and founder, Wang Huang; CFO Leon Deng; and COO Mike Yeung. The call will begin at 8:00 a.m. ET U.S. / 9:00 p.m. China Standard Time. Participants can access the call by dialing +1-888-346-8982 or +1-412-902-4272 for international callers, and ask to be connected to the call for "Hua
- PRPromaxo Raises $4.17M in Funding Round Led by Huami CorporationOAKLAND, Calif. & CUPERTINO, Calif.--(BUSINESS WIRE)--Promaxo, Inc. (Promaxo), the medical imaging, robotics, and AI technology company, and Huami Corp. (NYSE: HMI) today announced closing an investment round of $4.17M led by Huami. “As an industry, we are just scratching the surface of how powerful MRI is poised to become in guided interventions, and we are proud to have Huami as a strategic investor as we introduce our truly open MRI system to the masses,” said Dr. Amit Vohra, founder and CEO of Promaxo. “We are thrilled to have the financial support to help execute our vision and look forward to providing the best healthcare possible to our patients and clinical partners.” Th